Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • WMB vs MRNA✓SelectedUSD · MRNAWMB vs MRNA performance historyLatest closeAs of-2.75%11/20
Stock and ETF performance explorer

WMB vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+102.0%
MRNA return
+153.9%
Excess return
-51.9%
Maximum drawdown
-18.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.8%-2.2%-0.6%-2.8%
7D-6.9%-12.7%+5.8%-7.0%
30D-11.7%-20.7%+9.0%-11.8%
3M-9.6%+46.3%-55.9%-9.4%
6M-16.2%+305.2%-321.4%-15.7%
YTD+9.3%+561.2%-551.9%+8.0%
1Y+12.5%+772.1%-759.6%+9.9%
3Y+102.0%+147.0%-44.9%+94.9%
All+102.0%+153.9%-51.9%+94.9%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling